首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >THE RESULTS OF PARATHYROID HORMONE ASSAY IN PARATHYROID ASPIRATES IN PRE-OPERATIVE LOCALIZATION OF PARATHYROID ADENOMAS FOR FOCUSED PARATHYROIDECTOMY IN PATIENTS WITH NEGATIVE OR SUSPICIOUS TECHNETIUM-99M-SESTAMIBI SCANS
【24h】

THE RESULTS OF PARATHYROID HORMONE ASSAY IN PARATHYROID ASPIRATES IN PRE-OPERATIVE LOCALIZATION OF PARATHYROID ADENOMAS FOR FOCUSED PARATHYROIDECTOMY IN PATIENTS WITH NEGATIVE OR SUSPICIOUS TECHNETIUM-99M-SESTAMIBI SCANS

机译:甲状旁腺激素测定结果在甲状旁腺腺瘤前甲状旁腺腺瘤前甲状腺腺瘤的预术定位的结果为负面或可疑技术-99M-Sestamibi扫描的患者聚焦甲状旁腺切除术

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: This study aimed to evaluate the results of parathyroid hormone (PTH) assay in parathyroid aspirates to determine uniglandular disease by an endocrinologist-performed ultrasound (US) in patients with discordant or negative technetium-sestamibi scans and to evaluate whether this procedure increases the number of focused parathyroidectomies (FPs).
机译:目的:本研究旨在评估甲状旁腺激素(PTH)测定的结果,甲状旁腺吸气中的甲状腺功能脂蛋白患者对un中分泌患者的超声(US)进行核心疾病,以患有不和谐或负面技术 - Sestamibi扫描的患者,并评估该程序是否增加了 聚焦甲状旁腺切除术(FPS)的数量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号